These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34599843)

  • 1. Established pulmonary hypertension in rats was reversed by a combination of a HIF-2α antagonist and a p53 agonist.
    Zheng Q; Lu W; Yan H; Duan X; Chen Y; Zhang C; Luo X; Chen J; Wang C; Liu S; Li Y; Tang H; Rahimi S; Rahimi S; Yuan JX; Zhong N; Yang K; Wang J
    Br J Pharmacol; 2022 Mar; 179(5):1065-1081. PubMed ID: 34599843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertension.
    Wang Z; Yang K; Zheng Q; Zhang C; Tang H; Babicheva A; Jiang Q; Li M; Chen Y; Carr SG; Wu K; Zhang Q; Balistrieri A; Wang C; Song S; Ayon RJ; Desai AA; Black SM; Garcia JGN; Makino A; Yuan JX; Lu W; Wang J
    Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L216-L228. PubMed ID: 30358436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of HIF-2α mediated FoxM1 expression on proliferation of pulmonary artery smooth muscle cells in hypoxic rats].
    Zhu H; Zhu LM; Jiang YL; Hu RC; Dai AG
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(2):129-134. PubMed ID: 30669752
    [No Abstract]   [Full Text] [Related]  

  • 4. Endothelial HIF-2α contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition.
    Tang H; Babicheva A; McDermott KM; Gu Y; Ayon RJ; Song S; Wang Z; Gupta A; Zhou T; Sun X; Dash S; Wang Z; Balistrieri A; Zheng Q; Cordery AG; Desai AA; Rischard F; Khalpey Z; Wang J; Black SM; Garcia JGN; Makino A; Yuan JX
    Am J Physiol Lung Cell Mol Physiol; 2018 Feb; 314(2):L256-L275. PubMed ID: 29074488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smooth muscle cell-specific FoxM1 controls hypoxia-induced pulmonary hypertension.
    Dai J; Zhou Q; Tang H; Chen T; Li J; Raychaudhuri P; Yuan JX; Zhou G
    Cell Signal; 2018 Nov; 51():119-129. PubMed ID: 30092353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes Derived from Human Pulmonary Artery Endothelial Cells Shift the Balance between Proliferation and Apoptosis of Smooth Muscle Cells.
    Zhao L; Luo H; Li X; Li T; He J; Qi Q; Liu Y; Yu Z
    Cardiology; 2017; 137(1):43-53. PubMed ID: 28068653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia Upregulates Estrogen Receptor β in Pulmonary Artery Endothelial Cells in a HIF-1α-Dependent Manner.
    Frump AL; Selej M; Wood JA; Albrecht M; Yakubov B; Petrache I; Lahm T
    Am J Respir Cell Mol Biol; 2018 Jul; 59(1):114-126. PubMed ID: 29394091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of proximal pulmonary arterial cells from chronic thromboembolic pulmonary hypertension patients.
    Quarck R; Wynants M; Ronisz A; Sepulveda MR; Wuytack F; Van Raemdonck D; Meyns B; Delcroix M
    Respir Res; 2012 Mar; 13(1):27. PubMed ID: 22452949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of pulmonary vascular cell growth by hypoxia-inducible transcription factor-1α and hypoxia-inducible transcription factor-2α.
    Ahmad A; Ahmad S; Malcolm KC; Miller SM; Hendry-Hofer T; Schaack JB; White CW
    Am J Respir Cell Mol Biol; 2013 Jul; 49(1):78-85. PubMed ID: 23492195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgelin as a therapeutic target to prevent hypoxic pulmonary hypertension.
    Zhang R; Shi L; Zhou L; Zhang G; Wu X; Shao F; Ma G; Ying K
    Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(6):L574-83. PubMed ID: 24464808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apple polyphenol relieves hypoxia-induced pulmonary arterial hypertension via pulmonary endothelium protection and smooth muscle relaxation: In vivo and in vitro studies.
    Hua C; Zhao J; Wang H; Chen F; Meng H; Chen L; Zhang Q; Yan J; Yuan L
    Biomed Pharmacother; 2018 Nov; 107():937-944. PubMed ID: 30257406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Targeting of Vascular Remodeling and Right Heart Failure in Pulmonary Arterial Hypertension with a HIF-2α Inhibitor.
    Dai Z; Zhu MM; Peng Y; Machireddy N; Evans CE; Machado R; Zhang X; Zhao YY
    Am J Respir Crit Care Med; 2018 Dec; 198(11):1423-1434. PubMed ID: 29924941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apigenin attenuates pulmonary hypertension by inducing mitochondria-dependent apoptosis of PASMCs via inhibiting the hypoxia inducible factor 1α-KV1.5 channel pathway.
    He Y; Fang X; Shi J; Li X; Xie M; Liu X
    Chem Biol Interact; 2020 Feb; 317():108942. PubMed ID: 31930969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment.
    Veith C; Zakrzewicz D; Dahal BK; Bálint Z; Murmann K; Wygrecka M; Seeger W; Schermuly RT; Weissmann N; Kwapiszewska G
    Thromb Haemost; 2014 Dec; 112(6):1288-303. PubMed ID: 25231004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteolin ameliorates hypoxia-induced pulmonary hypertension via regulating HIF-2α-Arg-NO axis and PI3K-AKT-eNOS-NO signaling pathway.
    Ji L; Su S; Xin M; Zhang Z; Nan X; Li Z; Lu D
    Phytomedicine; 2022 Sep; 104():154329. PubMed ID: 35843187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRPC4 aggravates hypoxic pulmonary hypertension by promoting pulmonary endothelial cell apoptosis.
    Yang L; Peng Z; Gong F; Yan W; Shi Y; Li H; Zhou C; Yao H; Yuan M; Yu F; Feng L; Wan N; Liu G
    Free Radic Biol Med; 2024 Jul; 219():141-152. PubMed ID: 38636714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
    Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific HIF-2α (Hypoxia-Inducible Factor-2) Inhibitor PT2385 Mitigates Placental Dysfunction In Vitro and in a Rat Model of Preeclampsia (RUPP).
    Colson A; Depoix CL; Lambert I; Leducq C; Bedin M; De Beukelaer M; Gatto L; Loriot A; Peers de Nieuwburgh M; Bouhna K; Baldin P; Hubinont C; Sonveaux P; Debiève F
    Hypertension; 2023 May; 80(5):1011-1023. PubMed ID: 36876500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thioredoxin-1 mediates hypoxia-induced pulmonary artery smooth muscle cell proliferation.
    Chen B; Nelin VE; Locy ML; Jin Y; Tipple TE
    Am J Physiol Lung Cell Mol Physiol; 2013 Sep; 305(5):L389-95. PubMed ID: 23812635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma.
    Persson CU; von Stedingk K; Fredlund E; Bexell D; Påhlman S; Wigerup C; Mohlin S
    Exp Cell Res; 2020 Mar; 388(2):111845. PubMed ID: 31945318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.